Evidence map›Paper›PMID 24115933›Full record

ReviewFrontiers in pharmacology2013

Anti-cancer activities of pH- or heat-modified pectin.

Lionel Leclere, Pierre Van Cutsem, Carine Michiels

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
12.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 189 citations in OpenAlex.

  1. Review
  2. Article
  3. Spectroscopic and Microscopic Analysis of Apple Pectins.Molecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Prebiotics: Ignored player in the fight against cancer.Cancer reports (Hoboken, N.J.) · 2023
    Review
  9. Review
  10. Article
  11. Dietary Fiber from Soybean (Molecules (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Discovery of novel secretome CAZymes fromFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lionel LeclereUnité de Recherche en Biologie Cellulaire, Namur Research Institute for Life Sciences, University of Namur Namur, Belgium.
Pierre Van Cutsem
Carine Michiels
University of Namur · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite enormous efforts that have been made in the search for novel drugs and treatments, cancer continues to be a major public health problem. Moreover, the emergence of resistance to cancer chemotherapy often prevents complete remission. Researchers have thus turned to natural products mainly from plant origin to circumvent resistance. Pectin and pH- or heat-modified pectin have demonstrated chemopreventive and antitumoral activities against some aggressive and recurrent cancers. The focus of this review is to describe how pectin and modified pectin display these activities and what are the possible underlying mechanisms. The failure of conventional chemotherapy to reduce mortality as well as serious side effects make natural products, such as pectin-derived products, ideal candidates for exerting synergism in combination with conventional anticancer drugs.

Indexed as

apoptosiscancerchemopreventiondrug combinationgalectin-3pectin

Identifiers

PMID24115933
PMCPMC3792700
OpenAlexW2123505824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.